This study is a randomized controlled study to compare if a a non-invasive neurally adjusted ventilatory assist (NIV-NAVA) is better than nasal continuous positive airway pressure (N-CPAP) after extubation in infants' \< 30 weeks of gestation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
78
Seoul National University Children's Hospital
Seoul, South Korea
Extubation failure
Failure criteria * pH \< 7.2 with pCO2 \> 70mmHg confirmed by capillary blood gas analysis in spite of maximum settings * Severe apnea event requiring bag and mask resuscitation * FiO2 \>0.6 to maintain SpO2 ≥ 88% after extubation * Frequent desaturations (\< 85%) ≥ 3/hr not responding to increased ventilatory settings or an increase in Fio2 to 1.0
Time frame: extubation - 72 hours
FiO2 >0.6 to maintain SpO2 ≥ 88% after extubation
Participants will be followed for the extubation failure within 3 days after extubation
Time frame: extubation - 72 hours
Severe apnea event requiring bag and mask resuscitation
Participants will be followed for the extubation failure within 3 days after extubation
Time frame: extubation - 72 hours
FiO2 >0.6 to maintain SpO2 ≥ 88% after extubation
Participants will be followed for the extubation failure within 7 days after extubation
Time frame: extubation - 7 days
pH < 7.2 with pCO2 > 70mmHg confirmed by capillary blood gas analysis in spite of maximum settings
Participants will be followed for the extubation failure within 7 days after extubation
Time frame: extubation - 7 days
Severe apnea event requiring bag and mask resuscitation
Participants will be followed for the extubation failure within 7 days after extubation
Time frame: extubation - 7 days
Bronchopulmonary dysplasia
Participants will be followed for the duration of hospital stay
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: postmenstrual age 36 weeks
Duration of noninvasive ventilation
Participants will be followed for the duration of hospital stay
Time frame: postmenstrual age 40 weeks (until discharge)
Duration of inspired oxygen supply
Participants will be followed for the duration of hospital stay
Time frame: postmenstrual age 40 weeks (until discharge)
Duration of hospital stay
Participants will be followed for the duration of hospital stay
Time frame: postmenstrual age 40 weeks (until discharge)
Adverse events
Participants will be followed for 3 days after extubation
Time frame: extubation - 3days